v3.26.1
Net Income (Loss) per Share Attributable to Common and Limited Common Stockholders - Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations Anti-dilutive (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) 12,590,001 15,050,432 15,205,021 15,050,432
Employee Stock Option        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) 11,024,045 12,578,030 12,039,280 12,578,030
RSUs and PRSUs        
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]        
Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) 1,565,956 2,472,402 3,165,741 2,472,402